Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Click here to add this to my saved trials
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
Status: Enrolling
Updated:  7/14/2015
Semel Institute for Neuroscience and Human Behavior
mi
from
Los Angeles, CA
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
Status: Enrolling
Updated: 7/14/2015
Semel Institute for Neuroscience and Human Behavior
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer
A Randomized, Controlled Trial of Intraoperative Celiac Plexus Neurolysis for Patients With Operable (Resectable and Unresectable) Pancreatic and Periampullary Cancer
Status: Enrolling
Updated:  7/14/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer
A Randomized, Controlled Trial of Intraoperative Celiac Plexus Neurolysis for Patients With Operable (Resectable and Unresectable) Pancreatic and Periampullary Cancer
Status: Enrolling
Updated: 7/14/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Post-treatment Care of Breast Cancer Survivors
Post-treatment Care of Breast Cancer Survivors
Status: Enrolling
Updated:  7/14/2015
Columbia Unviersity Medical Center
mi
from
New York, NY
Post-treatment Care of Breast Cancer Survivors
Post-treatment Care of Breast Cancer Survivors
Status: Enrolling
Updated: 7/14/2015
Columbia Unviersity Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
A Phase II Study of Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory or -Ineligible, Advanced, Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  7/14/2015
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
A Phase II Study of Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory or -Ineligible, Advanced, Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 7/14/2015
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
A Phase II Study of Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory or -Ineligible, Advanced, Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  7/14/2015
University of New Mexico Cancer Center @ Lovelace Medical Center
mi
from
Albuquerque, NM
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
A Phase II Study of Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory or -Ineligible, Advanced, Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 7/14/2015
University of New Mexico Cancer Center @ Lovelace Medical Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated:  7/14/2015
Yale University
mi
from
New Haven, CT
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated: 7/14/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated:  7/14/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated: 7/14/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Wichita
mi
from
Wichita, KA
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
Altru Health Systems
mi
from
Grand Forks, ND
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated:  7/14/2015
Saskatchewan Cancer Agency
mi
from
Regina,
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors
Status: Enrolling
Updated: 7/14/2015
Saskatchewan Cancer Agency
mi
from
Regina,
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
Medcenter One Health System
mi
from
Bismarck, ND
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated:  7/14/2015
Allan Blair Cancer Centre
mi
from
Regina,
Genetic Study of Patients and Families With a History of Colorectal Cancer
The Familial Colorectal Neoplasia Collaborative Group
Status: Enrolling
Updated: 7/14/2015
Allan Blair Cancer Centre
mi
from
Regina,
Click here to add this to my saved trials
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated:  7/14/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated: 7/14/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated:  7/14/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated: 7/14/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated:  7/14/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated: 7/14/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated:  7/14/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated: 7/14/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated:  7/14/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis
Status: Enrolling
Updated: 7/14/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials